AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.
Chicago Tylenol murders still reverberates after 40 years; they changed medication packaging forever.
Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
As data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.
Patricia Gutierrez, PharmD, BCACP, CDE, aims to combat the challenges in culturally competent care with knowledge and love for her community and patients.
The increased negative health outcomes associated with migraines provide an opportunity for pharmacists in both the inpatient and outpatient setting to support patients.
Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.
By taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.
Finding the right medication or drug combination for individual patients is critical.
New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.
The therapy sustained IDFS benefit compared with ET alone.
American Institute of the History of Pharmacy posts the collection of pharmacist Daniel Shifrin on its website.
This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.
Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.
Pulmonary hypertension significantly increases the risk of disease progression and cardiovascular events in patients with myelofibrosis, emphasizing a need for routine screening.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.
In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management.
TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.
Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.